Registration of securities issued in business combination transactions

Quarterly Financial Information - Schedule of Balance Sheet (Detail)

v3.21.1
Quarterly Financial Information - Schedule of Balance Sheet (Detail) - USD ($)
Dec. 31, 2020
Sep. 30, 2020
Sep. 21, 2020
Jul. 02, 2020
Condensed Balance Sheet Statements, Captions [Line Items]        
Total Assets $ 692,373,510   $ 694,363,065  
Liabilities and Shareholders' Equity:        
Total current liabilities 421,572   1,790,393  
Deferred legal fees 239,161      
Derivative warrant liabilities 99,938,040   38,257,890  
Total liabilities 124,748,773   64,198,283  
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 562,624,730   625,164,780  
Shareholders' Equity:        
Additional Paid in Capital 68,899,593   6,360,169  
Accumulated deficit (63,902,585)   (1,362,540)  
Total shareholder's equity 5,000,007   5,000,002 $ 0
Total Liabilities and Shareholders' Equity 692,373,510   694,363,065  
Class A Ordinary Shares        
Shareholders' Equity:        
Common stock, value 1,274   648  
Total shareholder's equity 1,274     0
Class B Ordinary Shares        
Shareholders' Equity:        
Common stock, value 1,725   1,725  
Total shareholder's equity 1,725     $ 0
As Previously Reported        
Condensed Balance Sheet Statements, Captions [Line Items]        
Total Assets 692,373,510 $ 693,957,206 694,363,065  
Liabilities and Shareholders' Equity:        
Total current liabilities 421,572 1,052,132 1,790,393  
Deferred legal fees 239,161 239,161    
Deferred underwriting commissions   24,150,000    
Total liabilities 24,810,733 25,441,293 25,940,393  
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 662,562,770 663,276,660 663,422,670  
Shareholders' Equity:        
Additional Paid in Capital 5,931,243 5,204,860 5,071,351  
Accumulated deficit (933,235) (206,850) (73,340)  
Total shareholder's equity 5,000,007 5,000,002 5,000,002  
Total Liabilities and Shareholders' Equity 692,373,510 693,717,955 694,363,065  
As Previously Reported | Class A Ordinary Shares        
Shareholders' Equity:        
Common stock, value 274 267 266  
As Previously Reported | Class B Ordinary Shares        
Shareholders' Equity:        
Common stock, value 1,725 1,725 1,725  
Restatement Adjustment        
Liabilities and Shareholders' Equity:        
Derivative warrant liabilities 99,938,040 56,334,070 38,257,890  
Total liabilities 99,938,040 56,334,070 38,257,890  
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption (99,938,040) (56,334,070) (38,257,890)  
Shareholders' Equity:        
Additional Paid in Capital 62,968,350 19,364,816 1,288,818  
Accumulated deficit (62,969,350) (19,365,380) (1,289,200)  
Restatement Adjustment | Class A Ordinary Shares        
Shareholders' Equity:        
Common stock, value $ 1,000 564 $ 382  
Restatement Adjustment | Class B Ordinary Shares        
Shareholders' Equity:        
Common stock, value   0    
As Restated        
Condensed Balance Sheet Statements, Captions [Line Items]        
Total Assets   693,957,206    
Liabilities and Shareholders' Equity:        
Total current liabilities   1,052,132    
Deferred underwriting commissions   24,150,000    
Derivative warrant liabilities   56,334,070    
Total liabilities   81,536,202    
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption   606,942,590    
Shareholders' Equity:        
Additional Paid in Capital   24,569,676    
Accumulated deficit   (19,572,230)    
Total shareholder's equity   5,000,002    
Total Liabilities and Shareholders' Equity   693,478,794    
As Restated | Class A Ordinary Shares        
Shareholders' Equity:        
Common stock, value   831    
As Restated | Class B Ordinary Shares        
Shareholders' Equity:        
Common stock, value   $ 1,725